🔎 Trials Near Me

Почетна › Dijabetes tipa 2 › Тексас › Dallas

Kliničke studije za Dijabetes tipa 2 u gradu Dallas, TX

18 studija za Dijabetes tipa 2 traži učesnike na lokacijama u gradu Dallas i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.

Zvanični tekst studije (na engleskom)

Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar

Тражи се учесникФаза 3
  • University of Texas Southwestern Medical Center, Dallas
Узраст 18 и старији · Оба пола · Ажурирано 13. 11. 2026. · NCT07754461

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Тражи се учесникФаза 3
  • Soltero Cardiovascular Research Center, Dallas
  • North Texas Endocrine Center, Dallas
  • Southwest Family Medicine Associates, Dallas
  • и још 1
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT07064473

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Тражи се учесникФаза 3
  • Velocity Clinical Research, Dallas
Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT07351058

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Тражи се учесникФаза 3
  • Velocity Clinical Research, Dallas, Dallas
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07282600

A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus

Тражи се учесникФаза 3
  • Research Site, Dallas
Узраст 18 и старији · Оба пола · Ажурирано 30. 10. 2026. · NCT07662109

Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease

Тражи се учесникФаза 2
  • M3 Wake Research Dallas - Internal Medicine, Dallas
  • Revival Research Institute, LLC, Dallas
Узраст од 18 до 80 · Оба пола · Ажурирано 27. 10. 2026. · NCT07271186

A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus

Тражи се учесникФаза 3
  • Research Site, Dallas
Узраст 18 и старији · Оба пола · Ажурирано 22. 10. 2026. · NCT07662213

Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy

Тражи се учесникФаза 2
  • Zenos Clinical Research, Dallas
Узраст од 18 до 75 · Оба пола · Ажурирано 20. 10. 2026. · NCT07502508

The RESET System Pivotal Clinical Trial (Protocol Revision K)

Тражи се учесник
  • M3 Wake Research, Dallas
Узраст од 22 до 65 · Оба пола · Ажурирано 13. 10. 2026. · NCT04101669

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

Тражи се учесникФаза 2
  • Velocity Clinical Research - Dallas, Dallas
Узраст 18 и старији · Оба пола · Ажурирано 6. 10. 2026. · NCT07296484

Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema

Тражи се учесникФаза 3
  • North Texas Endocrine Center, Dallas
Узраст 18 и старији · Оба пола · Ажурирано 30. 9. 2026. · NCT07817251

NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients With Type 2 Diabetes: STRONG-DM Study

Тражи се учесник
  • University of Texas Southwestern Medical Center, Dallas
  • Parkland Health & Hospital System (PHHS), Dallas
  • Baylor Scott and White - Health System, Dallas
Сви узрасти · Оба пола · Ажурирано 29. 9. 2026. · NCT06593327

A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes

Тражи се учесникФаза 2
  • University of Texas Southwestern Medical Center, Dallas
Узраст од 18 до 75 · Оба пола · Ажурирано 11. 9. 2026. · NCT07415954

AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications

Тражи се учесникФаза 3
  • Thyroid Endocrinology & Diabetes PA, Dallas
  • Baylor Jack and Jane Hamilton, Dallas
Узраст 45 и старији · Оба пола · Ажурирано 1. 9. 2026. · NCT07797335

A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

Тражи се учесникФаза 3
  • Research Institute of Dallas, Dallas
Узраст од 10 до 17 · Оба пола · Ажурирано 7. 8. 2026. · NCT06739122

Polypill for Prevention of Cardiomyopathy

Тражи се учесникФаза 1/2
  • UT Southwestern Medical Center, Dallas
Узраст од 18 до 100 · Оба пола · Ажурирано 4. 8. 2026. · NCT06143566

HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes

Тражи се учесникФаза 2
  • Velocity Clinical Research Dallas, Dallas
Узраст 18 и старији · Оба пола · Ажурирано 23. 4. 2026. · NCT07546929

Assessing the Efficacy of Targeted Home Visits in the Management of Chronic Conditions

Тражи се учесник
  • UT Southwestern Medical Center, Dallas
Узраст од 18 до 60 · Оба пола · Ажурирано 10. 2. 2026. · NCT05168605

Studije za Dijabetes tipa 2 u drugim gradovima

Ostale studije u gradu Dallas

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.